首页> 外文期刊>癌と化学療法 >A case of recurrent gastric cancer effectively treated by combined chemotherapy of weekly paclitaxel (PTX) and CDDP
【24h】

A case of recurrent gastric cancer effectively treated by combined chemotherapy of weekly paclitaxel (PTX) and CDDP

机译:每周紫杉醇(PTX)和CDDP联合化疗有效治疗复发性胃癌一例

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

The patient was a 63-year-old man who underwent distal gastrectomy for advanced gastric cancer with lymph node metastasis and peritoneal dissemination. One year and eleven months after the operation,an increasing CA 19-9 concentration and metastases to the liver and peritoneum were observed. Oral TS-1 was given, but had to be discontinued because of anorexia and nausea. Chemotherapy consisting of paclitaxel (PTX) and CDDP was performed. PTX (80 mg/body) was administered weekly on day 1, 8 and 15, while CDDP (50 mg/body) was administered weekly on day 1 as one cycle. After two cycles of PTX/CDDP administration,metastases to the liver and peritoneum were not detected. The patient was treated with five courses of PTX/CDDP and survived without recurrence as of this writing. PTX/CDDP was associated with few adverse events in hospital visits, and thought to be an effective chemotherapy against recurrent gastric cancer.
机译:该患者是一名63岁的男性,因晚期胃癌伴淋巴结转移和腹膜扩散而接受了远端胃切除术。术后一年零十一个月,观察到CA 19-9浓度增加,并转移至肝和腹膜。已给予口服TS-1,但由于厌食和恶心而不得不停药。进行了由紫杉醇(PTX)和CDDP组成的化学疗法。在第1、8和15天每周一次服用PTX(80 mg /人),而在第1天每周一次服用CDDP(50 mg /人)作为一个周期。经过两个周期的PTX / CDDP给药,未检测到肝和腹膜转移。该患者接受了5个疗程的PTX / CDDP治疗,截至本文撰写时存活无复发。 PTX / CDDP与医院就诊中的不良事件很少相关,被认为是针对复发性胃癌的有效化疗方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号